Molecular genetic study of familial ALS in Japan

日本家族性 ALS 的分子遗传学研究

基本信息

  • 批准号:
    07457152
  • 负责人:
  • 金额:
    $ 3.84万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1995
  • 资助国家:
    日本
  • 起止时间:
    1995 至 1996
  • 项目状态:
    已结题

项目摘要

We report clinical characteristics of familial amyotrophic lateral sclerosis (FALS) with four different missense point mutations in exons 2,4, and 5 of the Cu/Zn superoxide dismutase (SOD) gene, that result in amino acid substitutions of histidine^<46> by arginine (H46R), leucine^<84> by valine (L84V), isoleucine^<104> by phenylalanine (I104F), and valine^<148> by isoleucine (V148I), in five Japanese families. Although features of progressive neurogenic muscular atrophy was common in patients of these families, patients of each family showed characteristic clinical features. In addition, spinal cords of sporadic cases with amyotrophic lateral sclerosis (ALS) and normal controls were immunohistochemically examined using antibodies for nitrotyrosine (NT) and Cu/Zn superoxide dismutase (SOD). Immunoreactivity for NT was densely detected in the motor neurons of ALS while that was not or was only minimally detected in those of controls. The staining was also found in the axons on motor neurons of ALS,but was not found in the controls. In contrast, although immunoreactivity for Cu/Zn SOD of the motor neurons was dense in the motor neurons, that was not different between the ALS and controls.These results suggest that familial ALS with different mutations of the Cu/Zn SOD gene showed each clinical characteristics, and that genetic mutations and clinical features are well correlated in familial ALS.Furthermore, nitration of protein tyrosine residue is upregulated in motor neurons of the spinal cord of ALS.
我们报告了家族性肌萎缩侧索硬化症的临床特征,在五个日本家系中,铜/锌超氧化物歧化酶基因外显子2、4和5有四个不同的错义点突变,导致组氨酸^&lt;46&gt;被精氨酸(H46R)、亮氨酸^&lt;84&gt;由valine(L84V)、异亮氨酸^&lt;104&gt;;苯丙氨酸(I104F)和valine^&lt;148&gt;由异亮氨酸(V148I)取代。虽然进行性神经源性肌肉萎缩的特征在这些家系的患者中很常见,但每个家系的患者都有独特的临床特征。另外,对散发性肌萎缩侧索硬化症(ALS)患者和正常对照组的脊髓进行了硝基酪氨酸(NT)和铜/锌超氧化物歧化酶(SOD)免疫组织化学染色。在ALS的运动神经元中,NT的免疫反应较密集,而在对照组中未检测到或仅有极少量的NT免疫反应。肌萎缩侧索硬化症患者运动神经元上的轴突也有这种染色,而对照组则未见。相反,尽管运动神经元中的铜锌超氧化物歧化酶免疫反应较密集,但肌萎缩侧索硬化症患者的运动神经元中铜锌超氧化物歧化酶的免疫反应强度与对照组无明显差异,提示具有不同铜锌超氧化物歧化酶基因突变的家族性肌萎缩侧索硬化症具有各自的临床特征,且家族性肌萎缩侧索硬化症患者脊髓运动神经元中酪氨酸蛋白残基的硝化作用上调。

项目成果

期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Abe, M.Aoki, and Y.Itoyama: "Differential diagnosis of early stage Huntington's disease from dentatorubral-pallidoluysian atrophy by DNA analysis" Eur.J.Neurol.2. 239-240 (1995)
K.Abe、M.Aoki 和 Y.Itoyama:“通过 DNA 分析对早期亨廷顿病与齿状红核-苍白球路易体萎缩进行鉴别诊断”Eur.J.Neurol.2。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Aoki.Y.Ifoyama: "Variance of the age ast on set in a Japasese bamily with ALS assoctated with a novel Culzn SOD gene mutation" Ann.Neurol. 37. 676-679 (1995)
M.Aoki.Y.Ifoyama:“患有 ALS 的日本家庭中年龄的差异与新的 Culzn SOD 基因突变有关”Ann.Neurol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Aoki, K.Abe, K.Houi, M.Ogasawara, Y.Matsubara, T.Kobayashi, S.Mochio, K.Narisawa, and Y.Itoyama: "Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn SOD mutation" Ann.Neurol.37. 676-679 (1995)
M.Aoki、K.Abe、K.Houi、M.Ogasawara、Y.Matsubara、T.Kobayashi、S.Mochio、K.Narisawa 和 Y.Itoyama:“日本肌萎缩侧索硬化症家庭发病年龄的差异
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Watanabe, S.Sakurai, K.Abe, M.Aoki, M.Sadahiro, K.Tabayashi, and Y.Itoyama: "Inductions of Cu/Zn SOD-and NOS-like immunoreactivities in rabbit spinal cord after transient ischemia" Brain Res.732. 69-74 (1996)
M.Watanabe、S.Sakurai、K.Abe、M.Aoki、M.Sadahiro、K.Tabayashi 和 Y.Itoyama:“短暂性缺血后兔脊髓中 Cu/Zn SOD 和 NOS 样免疫反应性的诱导”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
M.Watanabe, M.Aoki, K.Abe, M.Shoji, T.Iizuka, Y.Ikeda, K.Kurokawa, K.Kato, H.Sasaki, S.Hirai, and Y.Itoyama: "A novel missense point mutation (S134N) of the Cu/Zn superoxide dismutase gene in a patient with familial motor neuron disease" Human Mutation. 9
M.Watanabe、M.Aoki、K.Abe、M.Shoji、T.Iizuka、Y.Ikeda、K.Kurokawa、K.Kato、H.Sasaki、S.Hirai 和 Y.Itoyama:“小说的错义点
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITOYAMA Yasuto其他文献

ITOYAMA Yasuto的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITOYAMA Yasuto', 18)}}的其他基金

Establishment of a new disease entity as astrocytopathy, and studies on the pathogenesis and treatment for neuromyelitis optica
星形细胞病新病种的建立及视神经脊髓炎的发病机制和治疗研究
  • 批准号:
    22229008
  • 财政年份:
    2010
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Elucidate the pathomechanism of inclusion body myositis(IBM)
阐明包涵体肌炎(IBM)的发病机制
  • 批准号:
    22659167
  • 财政年份:
    2010
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Optic-spinal multiple sclerosis : clarification of pathogenesis, establishment of new disease entity and treatment
视脊髓多发性硬化症:发病机制的阐明、新疾病实体的建立和治疗
  • 批准号:
    19209032
  • 财政年份:
    2007
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
A Study on the Pathogenesis and Therapy of Optic-Spinal Multiple Sclerosis
视神经脊髓多发性硬化症的发病机制及治疗研究
  • 批准号:
    17390250
  • 财政年份:
    2005
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
COMPARATIVE ANALYSIS OF CLINICAL AND MOLECULAR IMMUNOLOGICAL PATHOGENESES IN SUBTYPES OF MULTIPLE SCLEROSIS IN JAPAN
日本多发性硬化症亚型临床及分子免疫病因比较分析
  • 批准号:
    15390271
  • 财政年份:
    2003
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Comparative analysis of molecular immunopathogenesis in optic-spinal and conventional multiple sclerosis
视神经脊髓病与传统多发性硬化症分子免疫发病机制的比较分析
  • 批准号:
    13470131
  • 财政年份:
    2001
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mutational analysis in dysferlin gene in patients with muscular dystrophy in Japanese populations.
日本人群肌营养不良症患者 Dysferlin 基因突变分析。
  • 批准号:
    12557058
  • 财政年份:
    2000
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Genetic analysis in families with amyotrophic lateral sclerosis
肌萎缩侧索硬化症家族的遗传分析
  • 批准号:
    11470144
  • 财政年份:
    1999
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Clinical epidemiology and analysis of pathomechanisms of optic-spinal form of multiple sclerosis
视脊髓型多发性硬化症的临床流行病学及发病机制分析
  • 批准号:
    09470150
  • 财政年份:
    1997
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Study of Immunomechanisms in HTLV-I-Associated Myelopathy(HAM)
HTLV-I相关性脊髓病(HAM)的免疫机制研究
  • 批准号:
    63480217
  • 财政年份:
    1988
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Is motor neuron death occurring in the cervical spinal cord in the early stages of development a phenomenon associated with the formation of the cervical region common to birds and mammals?
颈脊髓在发育早期发生的运动神经元死亡是否是与鸟类和哺乳动物常见的颈部区域形成相关的现象?
  • 批准号:
    23K06307
  • 财政年份:
    2023
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms and therapeutic targeting of motor neuron death in SMA
SMA 运动神经元死亡的机制和治疗靶向
  • 批准号:
    10334501
  • 财政年份:
    2020
  • 资助金额:
    $ 3.84万
  • 项目类别:
Mechanisms and therapeutic targeting of motor neuron death in SMA
SMA 运动神经元死亡的机制和治疗靶向
  • 批准号:
    10559530
  • 财政年份:
    2020
  • 资助金额:
    $ 3.84万
  • 项目类别:
Mechanisms and therapeutic targeting of motor neuron death in SMA
SMA 运动神经元死亡的机制和治疗靶向
  • 批准号:
    10087983
  • 财政年份:
    2020
  • 资助金额:
    $ 3.84万
  • 项目类别:
Analysis of motor neuron death focusing on nuclear body abnormality by dipeptide repeat protein
二肽重复蛋白分析以核体异常为主的运动神经元死亡
  • 批准号:
    17K09749
  • 财政年份:
    2017
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Enhanced respiratory plasticity in models of respiratory motor neuron death
呼吸运动神经元死亡模型中呼吸可塑性增强
  • 批准号:
    8635605
  • 财政年份:
    2014
  • 资助金额:
    $ 3.84万
  • 项目类别:
Enhanced respiratory plasticity in models of respiratory motor neuron death
呼吸运动神经元死亡模型中呼吸可塑性增强
  • 批准号:
    9014557
  • 财政年份:
    2014
  • 资助金额:
    $ 3.84万
  • 项目类别:
Enhanced respiratory plasticity in models of respiratory motor neuron death
呼吸运动神经元死亡模型中呼吸可塑性增强
  • 批准号:
    9212843
  • 财政年份:
    2014
  • 资助金额:
    $ 3.84万
  • 项目类别:
Mechanism of motor neuron death in ALS: transcription activity of ribosomal RNA gene and TDP-43
ALS 运动神经元死亡机制:核糖体 RNA 基因和 TDP-43 的转录活性
  • 批准号:
    22300117
  • 财政年份:
    2010
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Involvement of RNA-editing enzyme and multi-factor to motor neuron death in patients with sporadic amyotrophic lateral sclerosis
RNA编辑酶和多因素与散发性肌萎缩侧索硬化症患者运动神经元死亡的关系
  • 批准号:
    21591071
  • 财政年份:
    2009
  • 资助金额:
    $ 3.84万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了